Today: 12 May 2026
Legal & General share price slips as AI disruption worries keep UK insurers on edge
11 February 2026
2 mins read

Legal & General share price slips as AI disruption worries keep UK insurers on edge

London, Feb 11, 2026, 09:10 GMT — Regular session

  • Legal & General shares slipped roughly 0.5% in early London trading, changing hands near 264p.
  • Insurer shares have swung around following a sector-wide selloff, as investors fret that AI tools might upend how insurance gets distributed.
  • Legal & General’s full-year results land March 11, drawing investor attention next.

Shares in Legal & General Group Plc (LGEN.L) edged down early Wednesday, dropping 0.5% to 264.4 pence by 0910 GMT, with numbers on a 15-minute delay. Insurers continued to look shaky as fresh chatter swirled about AI tools potentially shaking up the insurance landscape.

European insurance stocks took another hit after Tuesday’s slump, with investors rattled by a sharp selloff in U.S. insurance brokers. The trigger: mounting fears that new AI-driven comparison tools might eat into fees and nudge customers to shop around. “We’re seeing knee-jerk reactions from investors as they panic before obtaining all the facts and make rational decisions,” said Dan Coatsworth, head of markets at AJ Bell, following Insurify’s rollout of its ChatGPT-based comparison tool. Reuters

Legal & General’s full-year results, set for release on March 11, mark the next big milestone. Investors are eyeing details on cash generation, capital returns, and the latest on pension risk transfer (PRT) deals—where insurers assume pension obligations. The group plans to drop its preliminary results at 0700 GMT.

L&G doesn’t operate like price-comparison sites or brokers—the names usually at the center of disruption talk. Its operations span retirement, workplace pensions, and asset management. Still, when a fresh risk theme rattles the sector, L&G shares often move in step with the broader UK life insurance group.

The company issued a brief update Monday, announcing Lucy Blanchard-Burton will take over as head of its Mastertrust and Independent Governance Committee. The master trust is now managing £41.9 billion for 2.2 million members. “Lucy’s appointment further strengthens our position as the UK’s largest DC pension provider,” Lesley-Ann Morgan, global head of defined contribution, said in the statement. Legal General Group

Legal & General earlier this month wrapped up the sale of its U.S. insurance business to Meiji Yasuda of Japan, unlocking £1.2 billion in Solvency II capital — the industry’s go-to metric for capital adequacy. “It strengthens our balance sheet, releases capital and enables us to accelerate growth in US Pension Risk Transfer,” chief executive António Simões said. The group now plans to return an extra £1 billion to shareholders, lifting its targeted 2026 share buyback to £1.2 billion. Legal General Group

That focus on capital returns keeps L&G in play, even on days when sector sentiment drives the story. Investors prize the shares for their yield, and in quieter growth periods, buybacks carry extra weight.

Next up, traders are eyeing whether the AI buzz sticks with brokers and comparison sites, or if it starts bleeding into how insurers think about their own costs and pricing. If shares of U.S. brokers stabilize, that could cool the frenzy around the theme.

Still, if investors come around to the idea that AI won’t shake up customer buying habits or regulator attitudes anytime soon, those fears might recede. If not, the risk is a sector-wide rerating—life insurers could get caught up too, even if their actual AI exposure is tough to pinpoint.

Legal & General’s calendar circles March 11 as the key date. Eyes are on solvency figures, cash generation, and buyback speed. Management’s comments on the PRT pipeline headed into the new financial year will also be scrutinized.

Stock Market Today

  • Nasdaq Top and Bottom Performing Stocks as of 11:01 a.m. EDT on May 12, 2026
    May 12, 2026, 12:20 PM EDT. As of 11:01 a.m. EDT on May 12, 2026, the Nasdaq market shows distinct leaders and laggards among stocks. Select market data from ICE Data Services reveals the top performers gaining momentum, while others face declines amid mixed sector performance. FactSet reference data and SEC filings from Quartr contributed to the analysis. The movements reflect ongoing investor reactions to earnings reports, economic indicators, and market sentiment. Market participants are watching these trends closely for portfolio adjustments.

Latest article

Tesla’s AI premium hits a real-world check as shares reverse from China-FSD rally

Tesla’s AI premium hits a real-world check as shares reverse from China-FSD rally

12 May 2026
Tesla shares fell 3.9% to $427.60 by midday Tuesday after April inflation data came in hotter than expected and Reuters reported slow progress in Tesla’s Texas robotaxi rollout. The stock had surged in recent days on optimism over AI and China, but concerns about execution and valuation resurfaced. Reuters tests found long waits and limited robotaxi availability in Austin, with about 50 Tesla vehicles versus over 250 for Waymo.
PayPal Stock Stalls Near $45 as Truist Cut Tests the Lores Turnaround

PayPal Stock Stalls Near $45 as Truist Cut Tests the Lores Turnaround

12 May 2026
PayPal shares hovered near $45 midday Tuesday, little changed despite a price target cut to $44 and a maintained Sell rating from Truist. The firm cited rising rewards spending and soft international payment volume. PayPal reported Q1 total payment volume up 11% to $463.96 billion, but projected a 3% drop in Q2 transaction margin dollars and a 9% decline in adjusted EPS.
Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

12 May 2026
Hims & Hers Health shares fell 14.6% to $24.89 Tuesday after a Q1 net loss of $92.1 million, reversing a $49.5 million profit a year ago. Revenue rose 4% to $608.1 million, but gross margin dropped to 65% from 73% as the company shifted from compounded GLP-1s to branded drugs like Wegovy and Ozempic. Subscribers climbed to 2.584 million, while monthly revenue per subscriber slipped to $80.

Popular

NatWest share price rises as buyback update lands, with February results next

NatWest share price rises as buyback update lands, with February results next

30 January 2026
NatWest shares rose 1.3% to 661.8 pence in early London trading after the bank disclosed buybacks of over 1.6 million shares on Jan. 28 and 29. The purchases come ahead of NatWest’s annual results, due Feb. 13. Investors are watching for updates on capital returns and management’s outlook. The stock hovered near its 52-week high earlier this month.
KKR stock steadies near $107 as investors await CFO update after 4% surge
Previous Story

KKR stock steadies near $107 as investors await CFO update after 4% surge

Marriott (MAR) stock jumps toward record high on luxury travel demand and credit-card fee outlook
Next Story

Marriott (MAR) stock jumps toward record high on luxury travel demand and credit-card fee outlook

Go toTop